Lens epithelial cell‐derived exosome inhibits angiogenesis in ocular pathological neovascularization through its delivery of miR ‐146a‐5p
The FASEB Journal · 2023-10 · 37 (10)
DOI: 10.1096/fj.202301020rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 08.09.2023. Verfasst von Ting Pan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Exosomes, Choroidal Neovascularization, MicroRNAs. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Abnormal ocular neovascularization, a major pathology of eye diseases, leads to severe visual loss. The role of lens epithelial cell (LEC)‐derived exosomes (Lec‐exo) is largely unknown. Thus, we aimed to investigate whether Lec‐exo can inhibit abnormal ocular neovascularization and explore the possible mechanisms. In our study, we proved the first evidence that exosomes derived from LECs attenuated angiogenesis in both oxygen‐induced retinopathy and laser‐induced choroidal neovascularization mice models. Further in vitro experiments proved that Lec‐exo inhibited proliferation, migration, and tube formation capability of human umbilical vein endothelial cells in high glucose condition. Further high‐throughput miRNAs sequencing analysis detected that miR‐146a‐5p was enriched in Lec‐exo. Mechanistically, exosomal miR‐146a‐5p was delivered to endothelial cells and bound to the NRAS coding sequence, which subsequently inactivated AKT/ERK signaling pathway. We successfully elucidated the function of Lec‐exo in inhibiting abnormal ocular neovascularization, which may offer a promising strategy for treatment of abnormal ocular neovascularization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Ophthalmology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.
- Department of Ophthalmology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
ORCID-Profile: Qinghuai Liu, Zizhong Hu
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Pan, T., Wu, Y., Zhang, X., Wang, J., Wang, X., Gu, Q., Xu, C., Fan, Y., Li, X., Xie, P., Liu, Q., & Hu, Z. (2023). Lens epithelial cell‐derived exosome inhibits angiogenesis in ocular pathological neovascularization through its delivery of miR ‐146a‐5p. The FASEB Journal, 37(10). https://doi.org/10.1096/fj.202301020rr
Vancouver
Pan T, Wu Y, Zhang X, Wang J, Wang X, Gu Q, et al. Lens epithelial cell‐derived exosome inhibits angiogenesis in ocular pathological neovascularization through its delivery of miR ‐146a‐5p. The FASEB Journal. 2023;37(10). doi:10.1096/fj.202301020rr
BibTeX
@article{Pan2023,
author = {Pan, Ting and Wu, Yan and Zhang, Xu and Wang, Jingfan and Wang, Xingxing and Gu, Qinyuan and Xu, Changlin and Fan, Yuanyuan and Li, Xinsheng and Xie, Ping and Liu, Qinghuai and Hu, Zizhong},
title = {Lens epithelial cell‐derived exosome inhibits angiogenesis in ocular pathological neovascularization through its delivery of miR ‐146a‐5p},
journal = {The FASEB Journal},
year = {2023},
volume = {37},
number = {10},
doi = {10.1096/fj.202301020rr}
}
EUVIMED